Neuroprotection in an animal model of retinal ischemia;Neuroprotektion bei ischamie der netzhaut im tiermodell

Ophthalmologe

Volumn 96, Issue 6, 1999, Pages 370-374

  Lagrèze, Wolf A ^a   Otto, Tim ^b   Feuerstein, Thomas J ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

Cerestat; Ischemia; Neuroprotection; Retina; Riluzole

Indexed keywords

APTIGANEL; MEMANTINE; RILUZOLE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT;

ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG ANTAGONISM; INTRAOCULAR PRESSURE; ISCHEMIA; MALE; PATHOLOGY; RETINA; RETINA BLOOD VESSEL; SPRAGUE DAWLEY RAT;

ANIMALS; INTRAOCULAR PRESSURE; ISCHEMIA; MALE; MEMANTINE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; RETINAL VESSELS;

EID: 0033146245     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050420     Document Type: Article

References (21)

1. Bormann J (1989) Memantine is a potent blocker of NMDA receptor channels. Eur J Pharmacol 66: 591-592
2. Choi D (1985) Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58: 293-297
3. Doble A (1997) Effects of riluzole on glutamatergic neurotransmission in the mammalian nervous system, and other pharmacological effects. Rev Contemp Pharmacother 8: 213-225
4. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114: 299-305
5. Fischer PA, Jacobi P, Schneider E, Schönberger B (1977) Die Wirkung intravenöser Gaben von Memantin bei Parkinson-Kranken. Arzneim Forsch 27: 1487-1489
6. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394
7. Hartveit E, Brandstätter JH, Sassoè-Pognetto M, Laurie DJ, Seeburg PH, Wässle H (1994) Localization and developmental expression of the NMDA receptor subunit NR2A in the mammalian retina. J Comp Neurol 348: 570-582
8. Huang M, Vinals AF, Dreyer EB (1996) The ability of Müller cells to detoxify extracellular glutamate is impaired under anoxic conditions. Invest Ophthalmol Vis Sci 37: S1043
9. Hughes WF (1991) Quantification of ischemic damage in the rat retina. Exp Eye Res 53: 573-582
10. Lagrèze WA, Knörle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39: 1063-1066
11. Louzada-Junior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, Coutinho-Netto J (1992) Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem 59: 358-363
12. Mam D, Lam K (1997) Neurotransmitters in the vertebrate retina. Invest Ophthalmol Vis Sci 38: 553-556
13. McBain CJ, Mayer M (1994) N-Methyl-D-Aspartic acid receptor structure and function. Physiol Rev 74: 723-760
14. Minematsu K, Fisher M, Li L, Sotak CH (1993) Diffusion and perfusion magnetic resonance imaging studies to evaluate a non-competitive NMDA antagonist and reperfusion in experimental stroke in rats. Stroke 24: 2074-2081
15. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258: 597-603
16. Olney JW (1982) The toxic effects of glutamate and related compounds in the retina and the brain. Retina 2: 341-359
17. Schmidt D, Schumacher M, Wakhloo AK (1992) Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol 113: 429-434
18. Seif el Nasr M, Peruche B, Roßberg C, Mennel H, Krieglstein J (1990) Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 185: 19-24
19. Szatkowski M, Barbour B, Attwell D (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348: 443-446
20. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB (1996) Chronic low-dose glutamate is toxic to retinal ganglion cells. Invest Ophthalmol Vis Sci 37: 1618-1624
21. Wahl F, Allix M, Plotkine M, Boulu RG (1993) Effect of riluzole on focal cerebral ischemia in rats. Eur J Pharmacol 230: 209-214